Skip to main content
. 2023 Dec 12;21(12):e8442. doi: 10.2903/j.efsa.2023.8442

TABLE 43.

Reported confirmed human cases of trichinellosis and notification rates per 100,000 population in EU MSs and non‐MS countries, by country and year, 2018–2022.

Country 2022 2021 2020 2019 2018
National coverage a Data format a Confirmed cases and rate Confirmed cases and rate Confirmed cases and rate Confirmed cases and rate Confirmed cases and rate
Cases Rate Cases Rate Cases Rate Cases Rate Cases Rate
Austria Y C 2 0.02 10 0.11 6 0.07 1 0.01 2 0.02
Belgium b Y A 0 0 0 0 0
Bulgaria Y A 9 0.13 29 0.42 13 0.19 55 0.79 45 0.64
Croatia Y C 0 0 17 0.42 0 0 3 0.07 0 0
Cyprus Y C 0 0 0 0 0 0 0 0 0 0
Czechia Y C 0 0 0 0 0 0 0 0 0 0
Denmark c
Estonia Y C 1 0.08 0 0 0 0 0 0 0 0
Finland d Y C 2 0.04 0 0 0 0 0 0 0 0
France Y C 15 0.02 2 < 0.01 1 < 0.01 2 < 0.01 0 0
Germany Y C 0 0 2 < 0.01 1 < 0.01 3 < 0.01 0 0
Greece Y C 0 0 0 0 0 0 0 0 0 0
Hungary Y C 0 0 0 0 0 0 0 0 2 0.02
Ireland Y C 0 0 0 0 0 0 0 0 0 0
Italy Y C 4 0.01 0 0 79 0.13 10 0.02 2 < 0.01
Latvia Y C 3 0.16 7 0.37 1 0.05 1 0.05 1 0.05
Lithuania Y C 0 0 1 0.04 0 0 0 0 0 0
Luxembourg Y C 0 0 0 0 0 0 0 0 0 0
Malta Y C 0 0 0 0 0 0 0 0 0 0
Netherlands Y A 0 0 0 0 0 0 1 0.01 0 0
Poland Y C 1 < 0.01 2 0.01 11 0.03 2 0.01 2 0.01
Portugal Y C 0 0 0 0 0 0 1 0.01 0 0
Romania Y C 4 0.02 6 0.03 4 0.02 6 0.03 10 0.05
Slovakia Y C 0 0 0 0 0 0 0 0 0 0
Slovenia Y C 0 0 0 0 0 0 0 0 0 0
Spain e Y C 0 0 1 1 12 0.03 2 0
Sweden Y C 0 0 0 0 0 0 0 0 0 0
EU Total 27 41 d 0.01 d 77 0.02 117 0.03 97 0.02 66 0.02
United Kingdom f Y C 0 0 0 0
EU Total 41 d 0.01 d 77 0.02 117 0.03 97 0.02 66 0.01
Iceland Y C 0 0 0 0 0 0 0 0 0 0
Norway Y C 0 0 0 0 0 0 0 0 0 0
Liechtenstein Y C 0 0 0 0 3 0.03 0 0 1 0.01
Switzerland g Y C 9 0.10 6 0.07

Abbreviation: –, Data not reported.

a

Y, yes; N, no; A, aggregated data; C, case‐based data.

b

Sentinel surveillance, notification rate not calculated.

c

No surveillance system.

d

The number of cases and confirmed cases*100,000 include two cases reported erroneously by Finland.

e

Data not complete for 2020–2021. Notification rate not calculated.

f

Cases reported by the United Kingdom for the period 2018–2019 were also taken into account for this estimation (EU‐28). Data for the United Kingdom were collected for the 2018–2019 period, since it was still an EU MS at that time. However, on 1 February 2020, it became a third country.

g

Until 2020, Switzerland provided data directly to EFSA. The human data for Switzerland include data from Liechtenstein for 2018–2020.